CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) $ in Millions		12 Months Ended
		Jun. 30, 2020		Jun. 30, 2019		Jun. 30, 2018
Net Sales		$ 70,950		$ 67,684		$ 66,832
Cost of Goods Sold (Deprecated 2018-01-31)		35,250		34,768		34,432
Selling, General and Administrative Expense		19,994		19,084		19,037
Goodwill & Indefinite Lived Intangible Asset Impairment Charges		0		8,345		0
Operating Income		15,706		5,487		13,363
Interest Expense		(465)		(509)		(506)
Investment Income, Interest		155		220		247
Other Nonoperating Income (Expense)		438		871		222
Earnings from Continuing Operations Before Income Taxes		15,834		6,069		13,326
Income Taxes on Continuing Operations		2,731		2,103		3,465
Net Earnings		13,103		3,966		9,861
Net Earnings Attributable to Noncontrolling Interest		76		69		111
Net Income (Loss) Attributable to Parent	[1]	$ 13,027		$ 3,897		$ 9,750
BASIC NET EARNINGS PER COMMON SHARE
Earnings Per Share, Basic	[2],[3]	$ 5.13		$ 1.45		$ 3.75
DILUTED NET EARNINGS PER COMMON SHARE
Earnings Per Share, Diluted	[2],[3]	$ 4.96	[4]	$ 1.43	[4],[5]	$ 3.67

[1] Net earnings attributable to Procter & Gamble in fiscal 2019 was negatively impacted by the impairment charges of $8.3 billion related to Shave Care goodwill and Gillette indefinite-lived intangible assets.

[2] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

[3] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

[4] Diluted net earnings/(loss) per share is calculated on Net earnings/(loss) attributable to Procter & Gamble.

[5] Diluted net earnings/(loss) per share in each quarter is computed using the weighted average number of shares outstanding during that quarter while Diluted net earnings/(loss) per share for the full year is computed using the weighted average number of shares outstanding during the year.  In the quarter ended June 30, 2019, the Company reported a Net loss attributable to P&G, driven by the Shave Care impairment charges discussed in Note 4.  This caused certain of our equity instruments to be antidilutive for the full year (preferred shares) and for the quarter ended June 30, 2019 (preferred shares and equity awards). Because these securities were dilutive during the first three quarters of this fiscal year, the sum of the four quarters' Diluted net earnings/(loss) per share will not equal the full-year Diluted net earnings per common share.